INVO Bioscience, Inc. (INVO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol INVO
- Company INVO Bioscience, Inc.
- Price $1.02
- Changes Percentage -17.74
- Change -0.22
- Day Low $1
- Day High $1.24
- Year High $3.5
- Year Low $0.5
- Market Cap $3,984,191
- Price Avg 50 EMA (D) $0.77
- Price Avg 200 EMA (D) $0.93
- Exchange NASDAQ
- Volume 3,585,534
- Average Volume 1,046,968
- Open $1.19
- Previous Close $1.24
- EPS 0.69
- PE 1.48
- Earnings Announcement 2024-11-11 10:59:00
- Shares Outstanding $3,906,070
Company brief: INVO BIOSCIENCE, INC. (INVO )
- Healthcare
- Medical - Devices
- Mr. Steven M. Shum
- https://www.invobio.com
- US
- N/A
- 11-02-2020
- US44984F4019
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
INVO Corporation News
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
globenewswire.com -- Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases Combined company to expand portfolio of clinical & commercial-stage assets in...